Elevated CA 125 in chronic liver disease with ascites [1];CA 125 elevado en la hepatopatía crónica con ascitis

Gastroenterologia y Hepatologia

Volumn 27, Issue 9, 2004, Pages 558-

  Crespo Valades E ^a   Malmierca Corral, M ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; FUROSEMIDE; OMEPRAZOLE; SPIRONOLACTONE;

AGED; ASCITES; ASCITES FLUID; CASE REPORT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; ECHOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; HEPATITIS C; HUMAN; LETTER; LIVER CIRRHOSIS; OVARY CARCINOMA; PHYSICAL EXAMINATION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL;

EID: 19744380965     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13068143     Document Type: Letter

References (10)

1. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human Ovarian Carcinoma. J Clin Invest 1981;68:1331-7.
2. Jiménez Lacave A, Allende Monclús M. Falsos negativos y positivos de los marcadores tumorales: sus limitaciones en la práctica clínica. Aplicaciones clínicas al CA-125. Rev Clin Esp 2001;201:715-7.
3. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-7.
4. Sevine A, Camci C, Turk HM, Buyukberber S. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma. Oncology 2003;65:1-6.
5. Miralles C, Orea M, España P, Provencio M, Sánchez A, Cantos B, et al. Cancer Antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003;10: 150-4.
6. Bergmann JF, Beaugrand M, Labadie H, Bidart JM, Bohuon C. CA 125 (ovarian tumor-associated antigen) in ascitic liver diseases. Clin Chim Acta 1986;155:163-5.
7. Ruibal A, Siurana R. Evidence of a relationship between high serum CA 125 and liver failure pattern in cirrhotic patients without ascitis and jaundice. Int J Biol Markers 1986;1:55-6.
8. Zuckerman E, Lanir A, Sabo E, Rosenvald-Zuckerman T, Matter I, Yeshurun D, et al. Cancer Antigen 125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterol 1999;94:1613-7.
9. Devarbhavi H, Kaese D, Williams AW, Rakela J, Klee GG, Kamath PS. Cancer Antigen 125 in patients with chronic liver disease. Mayo Clin Proc 2002;77:538-41.
10. Rubin J, Rockey DC. Cirrhotic ascites, ovarian carcinoma, and CA-125. South Med J 1999;92:248-50.